Differential susceptibility following β-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response

Behavioural Brain Research

Volumn 177, Issue 2, 2007, Pages 205-213

  Prediger, Rui D S ^a   Franco, Jeferson L ^a   Pandolfo, Pablo ^a   Medeiros, Rodrigo ^a   Duarte, Filipe S ^a   Di Giunta, Gabriella ^a   Figueiredo, Cláudia P ^a   Farina, Marcelo ^a   Calixto, João B ^a   Takahashi, Reinaldo N ^a   Dafre, Alcir L ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Amyloid peptide; Alzheimer's disease; Glutathione (GSH); Glutathione reductase (GR); Gluthatione peroxidase (GPx); Mouse strain; Spatial learning; Synaptophysin

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE REDUCTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENILE PLAQUE; STRAIN DIFFERENCE; SYNAPSE; SYNAPSE VESICLE;

AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE SUSCEPTIBILITY; EXPLORATORY BEHAVIOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; REACTION TIME; SPACE PERCEPTION; SPECIES SPECIFICITY;

EID: 33846433513     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.11.032     Document Type: Article

References (63)

1. Abramov A.Y., Canevari L., and Duchen M.R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanisms of amyloid neurotoxicity. J Neurosci 23 (2003) 5088-5095
2. Agardh C.D., Agardh E., Hultberg B., and Ahren B. Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries. J Diabetes Complications 3 (2000) 146-153
3. Aksenov M.Y., and Markesbery W.R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 302 (2001) 141-145
4. Aksenov M.Y., Tucker H.M., Nair P., Aksenova M.V., Butterfield D.A., Estus S., et al. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci 11 (1999) 151-164
5. Apelt J., Bigl M., Wunderlich P., and Schliebs R. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer's-like pathology. Int J Dev Neurosci 22 (2004) 475-484
6. Barber V.S., and Griffiths H.R. Is glutathione an important neuroprotective effector molecule against amyloid beta toxicity?. Biofactors 17 (2003) 215-228
7. Barja G. Free radicals and aging. Trends Neurosci 27 (2004) 595-600
8. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 (1994) 817-827
9. Boyd-Kimball D., Sultana R., Mohmmad-Abdul H., and Butterfield D.A. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 79 (2005) 700-706
10. Boyd-Kimball D., Sultana R., Poon H.F., Mohmmad-Abdul H., Lynn B.C., Klein J.B., et al. Gamma-glutamylcysteine ethyl ester protection from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach. J Neurosci Res 79 (2005) 707-713
11. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
12. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid-β-peptide-associated free radical oxidative stress. Free Radic Biol Med 32 (2002) 1050-1060
13. Butterfield D.A., Drake J., Pocernich C., and Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role of amyloid beta-peptide. Trends Mol Med 7 (2001) 548-554
14. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R.E., Wyss-Coray T., et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/-mice: isoform-specific effects on neurodegeneration. J Neurosci 19 (1999) 4867-4880
15. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol 113 (1985) 484-490
16. Craft J.M., Watterson D.M., Frautschy S.A., and Van Eldik L.J. Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo. Neurobiol Aging 25 (2004) 1283-1292
17. Dringen R., and Hirrlinger J. Glutathione pathways in the brain. Biol Chem 384 (2003) 505-516
18. Farina M., Franco J.L., Ribas C.M., Meotti F.C., Missau F.C., Pizzolatti M.G., et al. Protective effects of Polygala paniculata extract against methylmercury-induced neurotoxicity in mice. J Pharm Pharmacol 57 (2005) 1503-1508
19. Flood J.F., Morley J.E., and Roberts E. Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer's disease. Proc Natl Acad Sci USA 88 (1991) 3363-3366
20. Franco J.L., Teixeira A., Meotti F.C., Ribas C.M., Stringari J., Garcia Pomblum S.C., et al. Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environ Res 102 (2006) 22-28
21. Giovanni A., Sieber B.A., Heikkila R.E., and Sonsalla P.K. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J Pharmacol Exp Ther 257 (1991) 691-697
22. Giustarini D., Rossi R., Milzani A., Colombo R., and Dalle-Donne I. S-Glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8 (2004) 201-212
23. Haass C., and De Strooper B. The presenilins in Alzheimer's disease: proteolysis holds the key. Science 286 (1999) 916-919
24. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 45 (2005) 51-88
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
26. Jhoo J.H., Kim H.C., Nabeshima T., Yamada K., Shin E.J., Jhoo W.K., et al. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex. Behav Brain Res 155 (2004) 185-196
27. Kim H.C., Yamada K., Nitta A., Olariu A., Tran M.H., Mizuno M., et al. Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience 119 (2003) 399-419
28. Lehman E.J.H., Kulnane L.S., Gao Y., Petriello M.C., Pimpis K.M., Younkin L., et al. Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse. Hum Mol Genet 12 (2003) 2949-2956
29. Liu H., Harrell L.E., Shenvi S., Hagen T., and Liu R.M. Gender differences in glutathione metabolism in Alzheimer's disease. J Neurosci Res 79 (2005) 861-867
30. Lovell M.A., Ehmann W.D., Butler S.M., and Maresbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45 (1995) 1594-1601
31. Lyras L., Cairns N.J., Jenner A., Jenner P., and Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 68 (1997) 2061-2069
32. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 (1997) 134-147
33. Masilamoni J.G., Jesudason E.P., Jesudoss K.S., Murali J., Paul S.F., and Jayakumar R. Role of fibrillar Abeta25-35 in the inflammation induced rat model with respect to oxidative vulnerability. Free Radic Res 39 (2005) 603-612
34. Masliah E., Achim C.L., Ge N., DeTeresa R., Terry R.D., and Wiley C.A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32 (1992) 321-329
35. Maurice T., Lockhart B.P., and Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706 (1996) 181-193
36. McDonald J.R., Hong N.S., and Devan B.D. The challenges of understanding mammalian cognition and memory-based behaviours: an interactive learning and memory systems approach. Neurosci Biobehav Rev 28 (2004) 719-745
37. Minich T., Riemer J., Schulz J.B., Wielinga P., Wijnholds J., and Dringen R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97 (2006) 373-384
38. Morris R.G.M., Garrud P., Rawlins J.N.P., and O'keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1992) 681-683
39. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170 (1994) 63-66
40. O'Brian C.A., and Chu F. Post-translational disulfide modifications in cell signaling role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic Res 39 (2005) 471-480
41. Ono K., Hamaguchi T., Naiki H., and Yamada M. Anti-amyloidogenic effects of antioxidants: Implications for the prevention and therapeutics of Alzheimer's disease. Biochem Biophys Acta 1762 (2006) 575-586
42. Packard M.G., and Knowlton B.J. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 25 (2001) 563-593
43. Perry T.L., Yong V.W., Bergeron C., Hansen S., and Jones K. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol 21 (1987) 331-336
44. Prediger R.D.S., Pamplona F.A., Fernandes D., and Takahashi R.N. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD)-the spontaneously hypertensive rat (SHR). Int J Neuropsychopharmacol 8 (2005) 583-594
45. Rahman Q., Abidi P., Afaq F., Schiffman D., Mossman B.T., Kamp D.W., et al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol 29 (1999) 543-568
46. Ran Q., Gu M., Van Remmen H., Strong R., Roberts J.L., and Richardson A. Glutathione peroxidase 4 protects cortical neurons form oxidative injury and amyloid toxicity. J Neurosci Res 84 (2006) 202-208
47. Riachi N.J., and Harik S.I. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier. Life Sci 42 (1988) 2359-2363
48. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30 (2001) 1191-1212
49. Schuessel K., Schafer S., Bayer T.A., Czech C., Pradier L., Muller-Spahn F., et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 18 (2005) 89-99
50. Schwartz A.G., and Pashko L.L. Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity. Ageing Res Rev 3 (2004) 171-187
51. Sedelis M., Schwarting R.K., and Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125 (2001) 109-125
52. Selkoe D. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
53. Spooner E.T., Desai R.V., Mori C., Leverone J.F., and Lemere C.A. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol. Vaccine 21 (2002) 290-297
54. Terranova J.P., Kan J.P., Storme J.J., Perreaut P., Le Fur G., and Soubrie P. Administration of amyloid β-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound. Neurosci Lett 213 (1996) 79-82
55. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ana Biochem 27 (1969) 502-522
56. Wendel A. Glutathione peroxidase. Methods Enzymol 77 (1981) 325-333
57. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22 (2002) 1858-1867
58. White N.M., and McDonald R.J. Multiple parallel memory systems in the brain of the rat. Neurobiol Learn Mem 77 (2002) 125-184
59. Woltjer R.L., Nghiem W., Maezawa I., Milatovic D., Vaisar T., Montine K.S., et al. Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J Neurochem 93 (2005) 1047-1056
60. Yamaguchi Y., Miyashita H., Tsunekawa H., Mouri A., Kim H.C., Saito K., et al. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET14460), on learning impairments induced by amyloid-β1-40 in the rat. J Pharmacol Exp Ther 317 (2006) 1079-1087
61. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., et al. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133 (2001) 89-96
62. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 250 (1996) 279-282
63. Yoshida M., Goto K., and Watanabe S. Task-dependent strain difference of spatial learning in C57BL/6N and BALB/c mice. Physiol Behav 73 (2001) 37-42